Want to join the conversation?
$DGX, which competes with $BRLI and $LH, said it expects 2016 revenue to be between $7.52Bil and $7.59Bil, an increase of 1.5-2.5% on an equivalent basis. Equivalent revenue will exclude the 2015 revenues associated with the company's clinical trials business. Adjusted diluted EPS, excluding amortization, is expected to be $5.02-5.17.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.